Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)

• Status: Completed
• Trial end date: 2015-05-03
• Target enrollment: 0
• Participant gender: All

Summary

A study to evaluate patient satisfaction, aesthetic and psychological impact of combined treatment with BOTOX® Cosmetic (onabotulinumtoxinA), JUVÉDERM® ULTRA XC, JUVÉDERM® ULTRA PLUS XC, JUVÉDERM® VOLUMA® XC, and LATISSE® (bimatoprost ophthalmic solution).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: abobotulinumtoxinA; Bimatoprost; Botulinum Toxins; Botulinum Toxins, Type A; Hyaluronic Acid; incobotulinumtoxinA; onabotulinumtoxinA; Ophthalmic Solutions

Criteria

Inclusion Criteria:

• Qualified to receive treatment with BOTOX® Cosmetic, a facial filler (JUVÉDERM® ULTRA XC and/or JUVÉDERM® ULTRA Plus XC and/or JUVÉDERM® VOLUMA® XC) and LATISSE® treatment

• Naïve to botulinum toxin therapy of any serotype for any indication

• Naïve to prescription eyelash growth products of any type

• Naïve to dermal filler treatment in the face and neck

Exclusion Criteria:

• Undergone facial plastic surgery, tissue grafting, tissue augmentation or facial dermal filler injections

• Had laser, photomodulation, intense pulsed light, radio frequency, dermabrasion or chemical peel in the face or neck

• Have received skin resurfacing (laser, photomodulation, intense pulsed light, radio frequency, dermabrasion, chemical peel, or non-ablative procedures) in the face or neck within 3 months

• Systemic retinoid therapy within 1 year prior to study enrollment

• Presence of inflammation at the proposed injection site(s)

• Profound atrophy/excessive weakness of muscles in target areas of injection

• Known immunization or hypersensitivity to any botulinum toxin serotype

• Undergone oral surgery or dental procedures within 30 days

• No visible eyelashes

• Use of permanent eyeliner, eyelash implants, semi-permanent eyelash tint, dye or extension

• Use of prescription eyelash growth products

• Unwilling or unable to remove contact lenses prior to study medication application in the evening and keep lenses out for 30 minutes

• Diagnosis of myasthenia gravis, Eaton-Lambert Syndrome, amyotrophic lateral sclerosis, or any other disease that might interfere with neuromuscular function.